Therapeutic Effect of Omalizumab in Severe Asthma: A Real-World Study in Korea

PURPOSE: Omalizumab, an anti-immunoglobulin E (IgE) monoclonal antibody, has proved to be effective for the treatment of severe asthma. However, there is no direct evidence of effectiveness of omalizumab in Korean patients with severe asthma. We sought to evaluate the real-world effectiveness of oma...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Allergy Asthma Immunol Res
Main Authors: Lee, Ji-Ho, Lee, Hyun Young, Jung, Chang-Gyu, Ban, Ga-Young, Shin, Yoo Seob, Ye, Young-Min, Nahm, Dong-Ho, Park, Hae-Sim
Formato: Artigo
Idioma:Inglês
Publicado: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2018
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5809760/
https://ncbi.nlm.nih.gov/pubmed/29411552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4168/aair.2018.10.2.121
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares